Drugs that contain Cariprazine Hydrochloride

1. Drug name - VRAYLAR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7943621 ALLERGAN Salts of piperazine compounds as D3/D2 antagonists
Dec, 2028

(6 years from now)

US7737142 ALLERGAN (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
Sep, 2029

(6 years from now)

CN1829703B ALLERGAN As A D 3 /D 2 Receptor Antagonist (Thio) Carbamoyl-Cyclohexane Derivatives
May, 2024

(1 year, 7 months from now)

CN1829703A ALLERGAN As D
May, 2024

(1 year, 7 months from now)

CN101679315A ALLERGAN Novel Piperazine Salts As D3/D2 Antagonists
May, 2028

(5 years from now)

CN101679315B ALLERGAN A D <Sub> 3 </Sub> /D <Sub> 2 </Sub> A Piperazine Salt.
May, 2028

(5 years from now)

IN200904256P2 ALLERGAN Novel Piperazine Salts As D3/D2 Antagonists
May, 2028

(5 years from now)

IN293352B ALLERGAN A Process For The Preparation Of Novel Piperazine Salts As D3/D2 Antagonists
May, 2028

(5 years from now)

EP1663996A1 ALLERGAN (Thio)Carbamoyl-Cyclohexane Derivatives As D3/D2 Receptor Antagonists
May, 2024

(1 year, 7 months from now)

EP1663996B1 ALLERGAN (Thio)Carbamoyl-Cyclohexane Derivatives As D3/D2 Receptor Antagonists
May, 2024

(1 year, 7 months from now)

EP2155696A2 ALLERGAN Piperazine Salts As D3/D2 Antagonists
May, 2028

(5 years from now)

EP2155696B1 ALLERGAN Piperazine Salts As D3/D2 Antagonists
May, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE47350 ALLERGAN Pharmaceutical formulations containing dopamine receptor ligands Jul, 2029

(6 years from now)

Treatment: Treatment of schizophrenia and/or acute manic or mixed episodes associated with bipolar i disorder with cariprazine; treatment of schizophrenia with cariprazine; treatment of acute manic or mixed episodes associated with bipolar i disorder with cariprazine; treatment of depressive episodes associated with bipolar i disorder (bipolar depression) with cariprazine

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 1.5MG BASE CAPSULE;ORAL Prescription
EQ 3MG BASE CAPSULE;ORAL Prescription
EQ 4.5MG BASE CAPSULE;ORAL Prescription
EQ 6MG BASE CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.